Rebecca Yu | Searcharxiv

arXiv2025

Why Do Decision Makers (Not) Use AI? A Cross-Domain Analysis of Factors Impacting AI Adoption

Growing excitement around deploying AI across various domains calls for a careful assessment of how human decision-makers interact with AI-powered systems. In particular, it is essential to understand when decision-makers voluntarily choose to consult AI tools, which we term decision-maker adoption. We interviewed experts across four domains -- medicine, law, journalism, and the public sector -- to explore current AI use cases and perceptions of adoption. From these interviews, we identify key factors that shape decision-maker adoption of AI tools: the decision-maker's background, perceptions of the AI, consequences for the decision-maker, and perceived implications for other stakeholders. We translate these factors into an AI adoption sheet to analyze how decision-makers approach adoption choices through comparative, cross-domain case studies, highlighting how our factors help explain inter-domain differences in adoption. Our findings offer practical guidance for supporting the responsible and context-aware deployment of AI by better accounting for the decision-maker's perspective.

cs.HC↗

arXiv2020

Anatomically-Informed Deep Learning on Contrast-Enhanced Cardiac MRI for Scar Segmentation and Clinical Feature Extraction

Visualizing disease-induced scarring and fibrosis in the heart on cardiac magnetic resonance (CMR) imaging with contrast enhancement (LGE) is paramount in characterizing disease progression and quantifying pathophysiological substrates of arrhythmias. However, segmentation and scar/fibrosis identification from LGE-CMR is an intensive manual process prone to large inter-observer variability. Here, we present a novel fully-automated anatomically-informed deep learning solution for left ventricle (LV) and scar/fibrosis segmentation and clinical feature extraction from LGE-CMR. The technology involves three cascading convolutional neural networks that segment myocardium and scar/fibrosis from raw LGE-CMR images and constrain these segmentations within anatomical guidelines, thus facilitating seamless derivation of clinically-significant parameters. In addition to available LGE-CMR images, training used "LGE-like" synthetically enhanced cine scans. Results show excellent agreement with those of trained experts in terms of segmentation (balanced accuracy of $96\%$ and $75\%$ for LV and scar segmentation), clinical features ($2\%$ difference in mean scar-to-LV wall volume fraction), and anatomical fidelity. Our segmentation technology is extendable to other computer vision medical applications and to problems requiring guidelines adherence of predicted outputs.

eess.IV↗